Skip to main content

Table 2 Details of patients with very early inflammatory arthritis from whom follow-up synovial fluid samples were obtained in which neutrophil or lymphocyte apoptosis could be quantified

From: Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis

  RA Non-RA
    Persistent Resolving
  Neutrophil Lymphocyte Neutrophil Lymphocyte Neutrophil Lymphocyte
Number of patients from whom analyzable follow-up samples were available 10 7 11 11 11 13
Number of analyzable follow-up samples 16 12 25 26 17 21
Number of weeks after symptom onset when follow-up samples were collected (median [IQR]) 19 (15–38) 18 (13–39) 26 (14–46) 28 (14–46) 13 (9–28) 14 (9–22)
Number of patients in whom more apoptosis was seen in a follow-up sample than in the initial sample 2 2 6 4 4 7
Treatment received prior to follow-up joint aspiration where more apoptosis was seen at follow-up
   Nil 0 1 1 0 0 1
   Parenteral steroid 0 0 1 1 4 6
   DMARD 0 0 2 1 0 0
   Parenteral steroid + DMARD 2 1 2 2 0 0
Treatment received prior to follow-up joint aspiration where no more apoptosis was seen at follow-up
   Nil 2 0 0 0 3 2
   Parenteral steroid 1 0 4 6 4 4
   DMARD 0 0 0 0 0 0
   Parenteral steroid + DMARD 5 5 1 1 0 0
  1. DMARD, disease-modifying antirheumatic drug; IQR, interquartile range; RA, rheumatoid arthritis.